Omeros Corp (OMER)

Name: Omeros Corp (OMER) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name OMEROS CORP · CIK 0001285819 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated WA
Fiscal year ends Dec 31

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-24

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	$73.81M	$111.81M	$29.87M	$64.83M	$41.62M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	$902.0K	$865.0K	$512.0K	$1.08M	$1.41M
R&D Expense	$62.60M	$81.30M	$119.52M	$114.87M	$112.72M	$118.78M	$107.61M	$106.32M	$89.86M	$55.60M	$50.70M
Operating Income	-$72.82M	-$122.80M	-$166.95M	-$164.53M	-$163.39M	-$173.62M	-$156.92M	-$146.04M	-$112.22M	-$43.90M	-$54.28M
Depreciation & Amortization	n/a	$1.00M	$1.00M	$900.0K	$1.0K	$1.40M	$1.62M	$1.79M	$962.0K	$551.0K	$300.0K
EBITDA	n/a	-$121.80M	-$165.95M	-$163.63M	-$163.39M	-$172.22M	-$155.30M	-$144.25M	-$111.26M	-$43.34M	-$53.98M
Net Income	$124.83M	-$3.35M	-$156.81M	-$117.81M	$47.42M	$194.24M	-$138.06M	-$84.49M	-$126.76M	-$53.48M	-$66.75M
EPS (Diluted)	n/a	-$0.05	-$2.70	-$1.88	$0.76	$3.12	-$2.41	-$1.71	n/a	n/a	n/a
Total Assets	$286.83M	$325.63M	$277.08M	$378.27M	$590.97M	$419.27M	$181.04M	$136.97M	$95.94M	$116.33M	$67.28M
Long-Term Debt	n/a	$87.90M	$164.90M	$213.16M	$315.29M	$313.46M	$236.29M	n/a	n/a	$83.83M	$80.52M
Shareholders' Equity	-$51.35M	-$121.23M	-$182.61M	-$24.98M	$85.68M	$23.78M	-$120.75M	-$109.02M	-$100.16M	-$2.81M	-$37.45M
Cash & Equivalents	$1.99M	$9.66M	$3.40M	$7.11M	$11.01M	$100.81M	$10.50M	$3.08M	$5.86M	$3.39M	$2.22M
Operating Cash Flow	-$68.67M	-$116.09M	-$148.80M	$74.73M	-$86.48M	-$109.72M	-$100.09M	-$60.07M	-$103.74M	-$36.23M	-$51.50M
Capital Expenditures	$56.0K	$65.0K	$165.0K	$426.0K	$113.0K	$277.0K	$283.0K	$334.0K	$567.0K	$350.0K	$126.0K
Free Cash Flow	-$68.73M	-$116.16M	-$148.97M	$74.30M	-$86.60M	-$110.00M	-$100.37M	-$60.41M	-$104.30M	-$36.58M	-$51.63M
Share Repurchases	$9.88M	$0	$11.85M	$4.65M	$0	$0	n/a	n/a	n/a	n/a	n/a
Shares Outstanding	72.09M	71.67M	58.04M	61.13M	62.83M	62.63M	61.67M	54.20M	49.01M	48.21M	43.82M
Weighted Average Diluted Shares	n/a	n/a	n/a	n/a	62.74M	62.34M	57.18M	49.52M	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.05	-$2.70	-$1.88	$0.76	$3.12	-$2.41	-$1.71	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView